GNRSU Greenrose (PNK) falls to $0.000001 on 09 Mar 2026: liquidity is the key insight

The GNRSU stock plunged to $0.000001 in U.S. market hours on 09 Mar 2026, marking a -99.99933% one-day move versus the prior close of $0.15. Trading volume was light at 145 shares on the PNK exchange, underlining severe liquidity pressure. Investors should treat current price action as a technical collapse rather than an operational failure; Greenrose Holding Company Inc. (GNRSU) still reports positive per-share metrics but faces market microstructure and listing risks. We use Meyka AI real-time analysis to separate valuation lines from trading noise.

Price action and short-term drivers for GNRSU stock

GNRSU stock closed at $0.000001 after an intraday range of $0.000001–$0.000001, a -99.99933% change from the previous close of $0.15. The tiny volume of 145 shares and a market cap near $13.00 suggest the move is driven by extremely low liquidity and stop orders rather than new operational data. The stock shows a year high of $0.15 and a year low of $0.000001, signaling steep volatility in the past 12 months.

Fundamentals and valuation context for GNRSU stock

On reported trailing metrics, Greenrose Holding Company Inc. lists EPS 3.10 and book value per share $4.30, but the quoted share price has collapsed to microcent levels, producing distorted ratios such as a PE near 0.0000003 and a price to book near 0.000023. The company reports shares outstanding 12,853,627 and cash per share $0.56, while the current ratio is 0.21, and debt to equity is 1.57, highlighting tight liquidity despite positive per-share earnings.

Risks and catalysts shaping GNRSU stock performance

Primary near-term risk for GNRSU stock is liquidity and potential market delisting or suspension on the PNK exchange given the micro-price and low daily volume. There are no recent earnings announcements listed, so news-driven recovery is unlikely absent a material corporate event. Regulatory shifts in the cannabis sector or a capital raise could be catalysts, but both carry dilution risk. Investors should weigh sector headwinds in Healthcare and Drug Manufacturers when sizing exposure.

Technical setup and trading outlook for GNRSU stock

Technically, GNRSU sits far below its 50-day and 200-day averages ($0.15 each), confirming a breakdown. With average volume effectively unavailable, order execution risk is high and spreads will be wide. Short-term traders face near-impossible stop placement; longer-term holders face potential administrative actions on PNK. Key support is at $0.000001, with resistance clustered near the prior averages and the year high $0.15.

Meyka AI grade, model forecast and GNRSU stock analysis

Meyka AI rates GNRSU with a score out of 100: 67.04 | Grade B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, industry metrics, financial growth, key metrics, and analyst signals. Meyka AI’s forecast model projects a near-term yearly price of $0.00, reflecting the model inputs and current market quotes; compared with the current price of $0.000001, that implies an effective downside of -100.00%. Forecasts are model-based projections and not guarantees. This grade and model are informational, not investment advice.

Final Thoughts

GNRSU stock is a textbook microcap liquidity collapse: price at $0.000001, volume 145, and market cap about $13.00 on the PNK exchange in the United States. Fundamentals show per-share earnings and book value that do not match the trading quote, which points to market-structure distortion rather than a clean equity valuation. Meyka AI’s model currently projects a yearly price of $0.00, implying -100.00% from the quoted price; this underlines the model’s view that trading mechanics and potential market actions dominate near-term movement. For investors, key takeaways are risk management, watching for formal company updates or capital events, and treating GNRSU as a highly speculative holding. Use stop rules and position limits and consult multiple sources before acting. Meyka AI provides this AI-powered market analysis platform data for context; forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.